POS0170 ACHIEVEMENT OF TREAT TO TARGET MEASURES WITH UPADACITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: PHASE 2 RANDOMIZED SLEek CLINICAL TRIAL RESULTS Article Swipe

View

Eric F. Morand , J. Merrill , Martin Aringer , Zahi Touma , R. Furie , Karim R. Masri , Christopher D. Saffore , Ling Cheng , Ronald van Vollenhoven ·

YOU? · · 2025 · Open Access · · DOI: https://doi.org/10.1016/j.ard.2025.05.558

Related Topics

Medicine

Randomized Controlled Trial

Lupus Erythematosus

Internal Medicine

Immunology

Concepts

Medicine Randomized controlled trial Lupus erythematosus Internal medicine Immunology Antibody

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1016/j.ard.2025.05.558
OA Status: hybrid
Related Works: 10
OpenAlex ID: https://openalex.org/W4411416709

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4411416709

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1016/j.ard.2025.05.558

Digital Object Identifier
Title: POS0170 ACHIEVEMENT OF TREAT TO TARGET MEASURES WITH UPADACITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: PHASE 2 RANDOMIZED SLEek CLINICAL TRIAL RESULTS

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2025

Year of publication
Publication date: 2025-06-01

Full publication date if available
Authors: Eric F. Morand, J. Merrill, Martin Aringer, Zahi Touma, R. Furie, Karim R. Masri, Christopher D. Saffore, Ling Cheng, Ronald van Vollenhoven

List of authors in order
Landing page: https://doi.org/10.1016/j.ard.2025.05.558

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: hybrid

Open access status per OpenAlex
OA URL: https://doi.org/10.1016/j.ard.2025.05.558

Direct OA link when available
Concepts: Medicine, Randomized controlled trial, Lupus erythematosus, Internal medicine, Immunology, Antibody

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4411416709
doi	https://doi.org/10.1016/j.ard.2025.05.558
ids.doi	https://doi.org/10.1016/j.ard.2025.05.558
ids.openalex	https://openalex.org/W4411416709
fwci	0.0
type	article
title	POS0170 ACHIEVEMENT OF TREAT TO TARGET MEASURES WITH UPADACITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: PHASE 2 RANDOMIZED SLEek CLINICAL TRIAL RESULTS
biblio.issue
biblio.volume	84
biblio.last_page	457
biblio.first_page	456
topics[0].id	https://openalex.org/T10308
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9973000288009644
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2745
topics[0].subfield.display_name	Rheumatology
topics[0].display_name	Systemic Lupus Erythematosus Research
topics[1].id	https://openalex.org/T10200
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9940000176429749
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2745
topics[1].subfield.display_name	Rheumatology
topics[1].display_name	Rheumatoid Arthritis Research and Therapies
topics[2].id	https://openalex.org/T11616
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9940000176429749
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2720
topics[2].subfield.display_name	Hematology
topics[2].display_name	Autoimmune and Inflammatory Disorders Research
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C71924100
concepts[0].level	0
concepts[0].score	0.9539541602134705
concepts[0].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[0].display_name	Medicine
concepts[1].id	https://openalex.org/C168563851
concepts[1].level	2
concepts[1].score	0.560167133808136
concepts[1].wikidata	https://www.wikidata.org/wiki/Q1436668
concepts[1].display_name	Randomized controlled trial
concepts[2].id	https://openalex.org/C2775915377
concepts[2].level	3
concepts[2].score	0.4680964946746826
concepts[2].wikidata	https://www.wikidata.org/wiki/Q188297
concepts[2].display_name	Lupus erythematosus
concepts[3].id	https://openalex.org/C126322002
concepts[3].level	1
concepts[3].score	0.35489165782928467
concepts[3].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[3].display_name	Internal medicine
concepts[4].id	https://openalex.org/C203014093
concepts[4].level	1
concepts[4].score	0.29446732997894287
concepts[4].wikidata	https://www.wikidata.org/wiki/Q101929
concepts[4].display_name	Immunology
concepts[5].id	https://openalex.org/C159654299
concepts[5].level	2
concepts[5].score	0.11100581288337708
concepts[5].wikidata	https://www.wikidata.org/wiki/Q79460
concepts[5].display_name	Antibody
keywords[0].id	https://openalex.org/keywords/medicine
keywords[0].score	0.9539541602134705
keywords[0].display_name	Medicine
keywords[1].id	https://openalex.org/keywords/randomized-controlled-trial
keywords[1].score	0.560167133808136
keywords[1].display_name	Randomized controlled trial
keywords[2].id	https://openalex.org/keywords/lupus-erythematosus
keywords[2].score	0.4680964946746826
keywords[2].display_name	Lupus erythematosus
keywords[3].id	https://openalex.org/keywords/internal-medicine
keywords[3].score	0.35489165782928467
keywords[3].display_name	Internal medicine
keywords[4].id	https://openalex.org/keywords/immunology
keywords[4].score	0.29446732997894287
keywords[4].display_name	Immunology
keywords[5].id	https://openalex.org/keywords/antibody
keywords[5].score	0.11100581288337708
keywords[5].display_name	Antibody
language	en
locations[0].id	doi:10.1016/j.ard.2025.05.558
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S25650217
locations[0].source.issn	0003-4967, 1468-2060
locations[0].source.type	journal
locations[0].source.is_oa	False
locations[0].source.issn_l	0003-4967
locations[0].source.is_core	True
locations[0].source.is_in_doaj	False
locations[0].source.display_name	Annals of the Rheumatic Diseases
locations[0].source.host_organization	https://openalex.org/P4310319945
locations[0].source.host_organization_name	BMJ
locations[0].source.host_organization_lineage	https://openalex.org/P4310319945
locations[0].source.host_organization_lineage_names	BMJ
locations[0].license	cc-by-nc-nd
locations[0].pdf_url
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id	https://openalex.org/licenses/cc-by-nc-nd
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	Annals of the Rheumatic Diseases
locations[0].landing_page_url	https://doi.org/10.1016/j.ard.2025.05.558
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5036855659
authorships[0].author.orcid	https://orcid.org/0000-0002-9507-3338
authorships[0].author.display_name	Eric F. Morand
authorships[0].author_position	first
authorships[0].raw_author_name	E. Morand
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5110095722
authorships[1].author.orcid
authorships[1].author.display_name	J. Merrill
authorships[1].author_position	middle
authorships[1].raw_author_name	J. Merrill
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5091190600
authorships[2].author.orcid	https://orcid.org/0000-0003-4471-8375
authorships[2].author.display_name	Martin Aringer
authorships[2].author_position	middle
authorships[2].raw_author_name	M. Aringer
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5003819915
authorships[3].author.orcid	https://orcid.org/0000-0001-5177-2076
authorships[3].author.display_name	Zahi Touma
authorships[3].author_position	middle
authorships[3].raw_author_name	Z. Touma
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5113322804
authorships[4].author.orcid
authorships[4].author.display_name	R. Furie
authorships[4].author_position	middle
authorships[4].raw_author_name	R.A. Furie
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5066631826
authorships[5].author.orcid	https://orcid.org/0000-0002-2178-9747
authorships[5].author.display_name	Karim R. Masri
authorships[5].author_position	middle
authorships[5].raw_author_name	K. Masri
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5051851484
authorships[6].author.orcid	https://orcid.org/0000-0003-0396-2646
authorships[6].author.display_name	Christopher D. Saffore
authorships[6].author_position	middle
authorships[6].raw_author_name	C.D. Saffore
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5100384276
authorships[7].author.orcid
authorships[7].author.display_name	Ling Cheng
authorships[7].author_position	middle
authorships[7].raw_author_name	L. Cheng
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5012009272
authorships[8].author.orcid	https://orcid.org/0000-0001-6438-8663
authorships[8].author.display_name	Ronald van Vollenhoven
authorships[8].author_position	last
authorships[8].raw_author_name	R.F. van Vollenhoven
authorships[8].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1016/j.ard.2025.05.558
open_access.oa_status	hybrid
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	POS0170 ACHIEVEMENT OF TREAT TO TARGET MEASURES WITH UPADACITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: PHASE 2 RANDOMIZED SLEek CLINICAL TRIAL RESULTS
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T10308
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9973000288009644
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2745
primary_topic.subfield.display_name	Rheumatology
primary_topic.display_name	Systemic Lupus Erythematosus Research
related_works	https://openalex.org/W2899084033, https://openalex.org/W2748952813, https://openalex.org/W3031052312, https://openalex.org/W4389568370, https://openalex.org/W3032375762, https://openalex.org/W1995515455, https://openalex.org/W2080531066, https://openalex.org/W3108674512, https://openalex.org/W1506200166, https://openalex.org/W1489783725
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.1016/j.ard.2025.05.558
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S25650217
best_oa_location.source.issn	0003-4967, 1468-2060
best_oa_location.source.type	journal
best_oa_location.source.is_oa	False
best_oa_location.source.issn_l	0003-4967
best_oa_location.source.is_core	True
best_oa_location.source.is_in_doaj	False
best_oa_location.source.display_name	Annals of the Rheumatic Diseases
best_oa_location.source.host_organization	https://openalex.org/P4310319945
best_oa_location.source.host_organization_name	BMJ
best_oa_location.source.host_organization_lineage	https://openalex.org/P4310319945
best_oa_location.source.host_organization_lineage_names	BMJ
best_oa_location.license	cc-by-nc-nd
best_oa_location.pdf_url
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id	https://openalex.org/licenses/cc-by-nc-nd
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	Annals of the Rheumatic Diseases
best_oa_location.landing_page_url	https://doi.org/10.1016/j.ard.2025.05.558
primary_location.id	doi:10.1016/j.ard.2025.05.558
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S25650217
primary_location.source.issn	0003-4967, 1468-2060
primary_location.source.type	journal
primary_location.source.is_oa	False
primary_location.source.issn_l	0003-4967
primary_location.source.is_core	True
primary_location.source.is_in_doaj	False
primary_location.source.display_name	Annals of the Rheumatic Diseases
primary_location.source.host_organization	https://openalex.org/P4310319945
primary_location.source.host_organization_name	BMJ
primary_location.source.host_organization_lineage	https://openalex.org/P4310319945
primary_location.source.host_organization_lineage_names	BMJ
primary_location.license	cc-by-nc-nd
primary_location.pdf_url
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id	https://openalex.org/licenses/cc-by-nc-nd
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	Annals of the Rheumatic Diseases
primary_location.landing_page_url	https://doi.org/10.1016/j.ard.2025.05.558
publication_date	2025-06-01
publication_year	2025
referenced_works_count	0
abstract_inverted_index
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	9
citation_normalized_percentile.value	0.34828238
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False